HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ts Tsiskarishvili Selected Research

Rosacea (Acne Rosacea)

4/2019[PATHOGENETIC FEATURES AND METHODS FOR TREATMENT OF VARIOUS FORMS OF ROSACEA].
2/2019[THE RATIONALE FOR THE POSSIBLE ROLE OF DEMODEX FOLLICULORUM IN THE PATHOGENESIS OF ROSACEA].
9/2018[FEATURES OF ROSACEA PATHOGENESIS IN PERIMENOPAUSAL WOMEN].
2/2018[THE ROLE OF SOME VAZOACTIVE PEPTIDES IN THE PATHOGENESIS OF EARLY FORMES OF ROSACEA AND THE HEMOSTASIS SYSTEM].
1/2017[RISK-FSCTORS OF CARDIOVASCULAR DISEASE IN PATIENTS WITH ROSACEA].
3/2015[Capillary fragility and some hemostatic parameters in patients with rosacea].
3/2014[Angioprotectors in the treatment of rosacea].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ts Tsiskarishvili Research Topics

Disease

7Rosacea (Acne Rosacea)
04/2019 - 03/2014
4Skin Diseases (Skin Disease)
04/2019 - 03/2014
1Hypertension (High Blood Pressure)
03/2021
1Rhinophyma
04/2019
1Inflammation (Inflammations)
02/2018
1Thrombophilia
02/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Erythema
11/2016
1Vitiligo
11/2016
1Hyperpigmentation
11/2016
1Hemorrhage
03/2015

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2019 - 01/2017
3CytokinesIBA
04/2019 - 01/2017
2EnzymesIBA
04/2019 - 02/2018
2Interleukin-8 (Interleukin 8)IBA
09/2018 - 02/2018
2Peptides (Polypeptides)IBA
09/2018 - 02/2018
2LipidsIBA
01/2017 - 03/2015
1Antihypertensive Agents (Antihypertensives)IBA
03/2021
1Brimonidine Tartrate (Alphagan)FDA LinkGeneric
04/2019
1pimecrolimus (Elidel)FDA Link
04/2019
1SteroidsIBA
04/2019
1Monoclonal AntibodiesIBA
04/2019
1Ivermectin (Mectizan)FDA Link
04/2019
1ElementsIBA
02/2019
1MelatoninIBA
09/2018
1Indicators and Reagents (Reagents)IBA
09/2018
1Fibrinogen (Factor I)FDA Link
02/2018
1Therapeutic UsesIBA
11/2016
1AntioxidantsIBA
11/2016
1SeleniumIBA
11/2016
1Hemostatics (Antihemorrhagics)IBA
03/2015
1Rutin ForteIBA
03/2014

Therapy/Procedure

2Therapeutics
04/2019 - 11/2016
1Phototherapy (Light Therapy)
11/2016
1Ultraviolet Therapy (Therapy, Ultraviolet)
11/2016
1Tourniquets
03/2015